| 27107/34351 | US=1-B / Farmacologia Michael T. Treatment of myocardial ischemia. In: Brunton LL, Parker KL, Lazo JS. Goodman e Gilman's: the pharmacological basis of therapeutics. 11st ed. New York: McGraw-Hill, 2006. p. 823-44. ISBN 978-0-071-142280-3. ISQUEMIA MIOCARDICA. TRATAMENTO; DOENCA ISQUEMICA DO CORACAO; NITRATOS ORGANICOS; ANTAGONISTAS DOS CANAIS; ANTAGONISTAS DOS RECEPTORES ADRENERGICOS; COMPARACAO DE ESTRATEGIAS TERAPEUTICAS ANTIANGINOSOS; DOENCA VASCULAR PERIFERICA |
| 27108/34351 | US=1-B / Farmacologia Hoffman BB. Therapy of hypertension. In: Brunton LL, Parker KL, Lazo JS. Goodman e Gilman's: the pharmacological basis of therapeutics. 11st ed. New York: McGraw-Hill, 2006. p. 845-68. ISBN 978-0-071-142280-3. TERAPIA DA HIPERTENSAO; DIURETICOS; SIMPATOLITICOS; ANTAGONISTAS DOS CANAIS; INIBIDORES DA ENZIMA; CONVERSORA DE ANGIOTENSINA; ANTAGONISTAS DOS RECEPTORES DA ANGIOTENSINA; VASODILATADORES; TERAPIA NAO FARMACOLOGICA DA HIPERTENSAO; SELECAO DE MEDICAMENTOS ANTI-HIPERTENSIVOS; PACIENTES INDIVIDUAIS |
| 27109/34351 | US=1-B / Farmacologia Hoffman BB. Therapy of hypertension. In: Brunton LL, Parker KL, Lazo JS. Goodman e Gilman's: the pharmacological basis of therapeutics. 11st ed. New York: McGraw-Hill, 2006. p. 845-68. ISBN 978-0-071-142280-3. TERAPIA DA HIPERTENSAO; DIURETICOS; SIMPATOLITICOS; ANTAGONISTAS DOS CANAIS; INIBIDORES DA ENZIMA; CONVERSORA DE ANGIOTENSINA; ANTAGONISTAS DOS RECEPTORES DA ANGIOTENSINA; VASODILATADORES; TERAPIA NAO FARMACOLOGICA DA HIPERTENSAO; SELECAO DE MEDICAMENTOS ANTI-HIPERTENSIVOS; PACIENTES INDIVIDUAIS; DOPAMINERGICO |
| 27110/34351 | US=1-B / Farmacologia Roden DM. Antiarrhythmic drugs. In: Brunton LL, Parker KL, Lazo JS. Goodman e Gilman's: the pharmacological basis of therapeutics. 11st ed. New York: McGraw-Hill, 2006. p. 899-932. ISBN 978-0-071-142280-3. |
| 27111/34351 | US=1-B / Farmacologia Mahley RW, Bersot TP. Drug therapy for hypercholesterolemia and dyslipidemia. In: Brunton LL, Parker KL, Lazo JS. Goodman e Gilman's: the pharmacological basis of therapeutics. 11st ed. New York: McGraw-Hill, 2006. p. 933-66. ISBN 978-0-071-142280-3. TERAPIA MEDICAMENTOSA PARA HIPERCOLESTEROLEMIA; TERAPIA MEDICAMENTOSA PARA DISLIPIDEMIA; METABOLISMO DE LIPOPROTEINAS PLASMATICAS; HIPERLIPIDEMIA; ATEROSCLEROSE; TRATAMENTO MEDICAMENTOSO DA DISLIPIDEMIA |
| 27112/34351 | US=1-B / Farmacologia Hoogerwerf WA, Pasricha PJ. Pharmacotherapy of gastric acidity, peptic ulcers, and gastroesophageal reflux disease. In: Brunton LL, Parker KL, Lazo JS. Goodman e Gilman's: the pharmacological basis of therapeutics. 11st ed. New York: McGraw-Hill, 2006. p. 967-81. ISBN 978-0-071-142280-3. FARMACOTERAPIA DA ACIDEZ GASTRICA; ULCERAS PEPTICAS; DOENCA DE REFLUXO GASTROESOFAGICO; FISIOLOGIA DA SECRECAO GASTRICA; INIBIDORES DA BOMBA DE PROTOES; ANTAGONISTAS DOS RECEPTORES; DEFESA DA MUCOSA; SUCRALFATO; ANTIACIDOS; INIBIDORES DE ACIDO; CYTOPROTECTANTS; DOENCA DO REFLUXO GASTROESOFAGICO |
| 27113/34351 | US=2 / Biol/Mol Gülow K, Kaminski M, Krammer PH. Death receptor: the role of CD95/CD95 ligand signaling in apoptosis and cancer. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 3-30. ISBN 978-3-527-31237-5. RECEPTOR MORTE; SISTEMA CD95; SISTEMA CD95L; SINALIZACAO DA APOPTOSE; CANCER; MAQUINARIA APOPTOTICA; VIA INTRINSECA; VIA EXTRINSECA; MITOCONDRIAS; MECANISMOS DE RESISTENCIA; ANGIOGENESE |
| 27114/34351 | US=1-B / Farmacologia Pasricha PJ. Treatment og disorders of bowel motility and Walter flux; antiemetics; agents used in biliary and pancreatic disease. In: Brunton LL, Parker KL, Lazo JS. Goodman e Gilman's: the pharmacological basis of therapeutics. 11st ed. New York: McGraw-Hill, 2006. p. 983-1008. ISBN 978-0-071-142280-3. TRATAMENTO DO DISTURBIOS DA MOTILIDADE INTESTINAL; FLUXO DE WALTER; ANTIEMETICOS; AGENTES UTILIZADOS EM BILIAR; DOENCA PANCREATICA; MOTALIDADE GASTROINTESTINAL; AGENTES ANTIDIARREICOS; SINDROME DO INTESTINO IRRITAVEL; ANTIESPASMODICOS; ANTINAUSEANTES; AGENTES ANTIEMETICOS; DRONABINOL; DISTURBIOS GASTROINTESTINAIS VARIADO; ACIDOS BILIARES; AGENTES ANTIFLATULENCIA |
| 27115/34351 | US=1-B / Farmacologia Sellin JH, Pasricha PJ. Pharmacotherapy of inflammatory bowel disease. In: Brunton LL, Parker KL, Lazo JS. Goodman e Gilman's: the pharmacological basis of therapeutics. 11st ed. New York: McGraw-Hill, 2006. p. 1009-19. ISBN 978-0-071-142280-3. FARMACOTERAPIA DA DOENCA INFLAMATORIA INTESTINAL; DOENCA INFLAMATORIA DO INTESTINO; MESALAMINE; GLICOCORTICOIDES; AGENTES IMUNOSSUPRESSORES; TERAPIA ANTI-TNF; ANTIBIOTICOS; PROBIOTICOS; TERAPIA DA DOENCA INFLAMATORIA DO INTESTINO. NA GRAVIDEZ |
| 27116/34351 | US=1-B / Farmacologia Shapiro TA, Goldberg DE. Chemotherapy of protozoal infections: malaria. In: Brunton LL, Parker KL, Lazo JS. Goodman e Gilman's: the pharmacological basis of therapeutics. 11st ed. New York: McGraw-Hill, 2006. p. 1021-47. ISBN 978-0-071-142280-3. QUIMIOTERAPIA DE INFECCOES POR PROTOZOARIOS; MALARIA; BIOLOGIA DA INFECCAO MALARICA; CLASSIFICACAO DOS AGENTES ANTIMALARICOS; ARTEMISININA; ATOVAQUONE; DIAMINOPIRIMIDINAS; PROGUANILO; QUINOLINES; SULFONAMIDAS; SULFONAS; TETRACICLINAS |
| 27117/34351 | US=1-B / Farmacologia Phillips MA, Stanley SL Jr. Chemotherapy of protozoal infections: amebiasis, giardiasis, trichomoniasis, trypanosomiasis, leishmaniasis, and other protozoal infections. In: Brunton LL, Parker KL, Lazo JS. Goodman e Gilman's: the pharmacological basis of therapeutics. 11st ed. New York: McGraw-Hill, 2006. p. 1049-72. ISBN 978-0-071-142280-3. QUIMIOTERAPIA DE INFECCOES POR PROTOZOARIOS; AMEBIASE; GIARDIASE; TRICOMONIASE; TRIPANOSSOMIASE; LEISHMANIOSE; INFECCOES POR PROTOZOARIOS |
| 27118/34351 | US=1-B / Farmacologia Loukas A, Hotez PJ. Chemotherapy of helminth infections. In: Brunton LL, Parker KL, Lazo JS. Goodman e Gilman's: the pharmacological basis of therapeutics. 11st ed. New York: McGraw-Hill, 2006. p. 1073-91. ISBN 978-0-071-142280-3. QUIMIOTERAPIA DE INFECCOES POR HELMINTOS; TRATAMENTO DE INFECCOES HELMINTICAS; DROGAS ANTI-HELMINTICOS |
| 27119/34351 | US=1-B / Farmacologia Chambers HF. General principles of antimicrobial therapy. In: Brunton LL, Parker KL, Lazo JS. Goodman e Gilman's: the pharmacological basis of therapeutics. 11st ed. New York: McGraw-Hill, 2006. p. 1095-1110. ISBN 978-0-071-142280-3. |
| 27120/34351 | US=1-B / Farmacologia Petri WA Jr. Sulfonamides, trimethoprim-sulfamethoxazole, quinolones, and agents for urinary tract infections. In: Brunton LL, Parker KL, Lazo JS. Goodman e Gilman's: the pharmacological basis of therapeutics. 11st ed. New York: McGraw-Hill, 2006. p. 1111-26. ISBN 978-0-071-142280-3. SULFONAMIDAS; SULFAMETOXAZOL-TRIMETOPRIM; QUINOLONAS; INFECCOES DO TRATO URINARIO |
| 27121/34351 | US=1-B / Farmacologia Petri WA Jr. Penicillins, cephalosporins, and other b-lactam antibiotics. In: Brunton LL, Parker KL, Lazo JS. Goodman e Gilman's: the pharmacological basis of therapeutics. 11st ed. New York: McGraw-Hill, 2006. p. 1127-1154. ISBN 978-0-071-142280-3. PENICILINAS; CEFALOSPORINAS; ANTIBIOTICOS B-LACTAMICOS; INIBIDORES DA B-LACTAMASE |
| 27122/34351 | US=1-B / Farmacologia Chambers HF. Aminoglycosides. In: Brunton LL, Parker KL, Lazo JS. Goodman e Gilman's: the pharmacological basis of therapeutics. 11st ed. New York: McGraw-Hill, 2006. p. 1155-71. ISBN 978-0-071-142280-3. AMINOGLICOSIDEOS; AMINOGLICOSIDEOS, FEITOS ADVERSOS; ESTREPTOMICINA; GENTAMICINA; TOBRAMICINA; AMICACINA; NETILMICINA; CANAMICINA; NEOMICINA |
| 27123/34351 | US=2 / Biol/Mol Walczak H, Koschny R, Willen D, Schader MB, Sykora J, Ganten TM, Haas TL. Death receptor: the TRAIL receptor-ligand system: biochemistry of apoptosis induction, therapeutic potential for cancer treatment and physiological function. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 31-92. ISBN 978-3-527-31237-5. RECEPTOR MORTE; SISTEMA DE RECEPTOR-LIGANTE TRAIL; BIOQUIMICA DA INDUCAO DE APOPTOSE; POTENCIAL TERAPEUTICO; CANCER. TERAPIA; FUNCAO FISIOLOGICA; ATIVACAO DA CASPASE; FAMILIA BCL-2; UBIQUITINA; TERAPIA GENETICA; INFECCAO VIRAL; IMUNOPATOLOGIAS; DOENCAS AUTO-IMUNES; TRANSPLANTE ALOGENICO DE CELULAS-TRONCO HEMATOPOETICAS |
| 27124/34351 | US=2 / Biol/Mol Wajant H. Death receptor: mechanisms of tumor necrosis factor-induced cell death. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 93-119. ISBN 978-3-527-31237-5. RECEPTOR DE MORTE; MORTE CELULAR; FATOR DE NECROSE TUMORAL; APOPTOSE; CANCER. TERAPIA |
| 27125/34351 | US=2 / Biol/Mol Micheau O. Death receptor: cellular FLICE-inhibitory protein: an update. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 120-56. ISBN 978-3-527-31237-5. CANCER; RECEPTOR MORTE; PROTEINA INIBITORIA DA FLICE; GENE FLIP |
| 27126/34351 | US=1-B / Farmacologia Chambers HF. Protein synthesis inhibitors and miscellaneous antibacterial agents. In: Brunton LL, Parker KL, Lazo JS. Goodman e Gilman's: the pharmacological basis of therapeutics. 11st ed. New York: McGraw-Hill, 2006. p. 1173-202. ISBN 978-0-071-142280-3. INIBIDORES DA SINTESE DE PROTEINAS; AGENTES ANTIBACTERIANOS VARIADO; TETRACICLINAS; CLORANFENICOL; MACROLIDEOS; QUETOLIDOS; TELITROMICINA; CLINDAMICINA; QUINUPRISTIN; DALFOPRISTIN; LINEZOLIDA; VANCOMICINA |